FDA: Class I recall of Arrow Endurance Extended Dwell Peripheral Catheter System

Editor's Note

The Food and Drug Administration (FDA), on June 26, identified the recall by Teleflex, and their subsidiary Arrow International, of the Arrow Endurance Extended Dwell Peripheral Catheter System as Class I, the most serious.

The recall was initiated because of the risk of catheter separation and leakage. If the catheter separates, fragments could be left in the bloodstream and cause serious injury including pulmonary embolism, heart attack, or death.

The company has received 83 complaints, 18 reported injuries, and no deaths related to this issue.

Distribution dates were October 26, 2018, to May 10, 2023.